How to Approach an Increasingly Challenging and Subjective Japanese Pricing Environment L.E.K. Consulting Read more
Related Practice Life Sciences & Pharma Japan remains on balance an attractive pharmaceutical market, with favorable volume dynamics, generally attractive pricing and broad and unfettered market access. 01022024160129
Article Life Sciences & Pharma AI and Biopharma: New Solutions Emerging Across the US Value Chain December 6, 2024
Published Articles Life Sciences & Pharma In need of an all-inclusive trip: socio-demographic diversity in psychedelic research November 8, 2024
Article Healthcare Services Healthcare Crossroads? The 2024 Election and What’s Really at Stake October 29, 2024
Executive Insights Life Sciences & Pharma Preparing for Innovation: A Maturity Framework for Artificial Intelligence in Life… August 2, 2024
Case Study Biotech and Pharmaceuticals Reimbursement Assessment for a Therapy for Hemodialysis Patients May 3, 2024 A biopharmaceutical company with a novel treatment of chronic kidney disease-associated pruritus asked L.E.K. to assess the potential risk of bundling of…
Executive Insights Diagnostics, Tools and Personalized Medicine Commercial Excellence in Life Sciences Tools and Services Companies April 8, 2024
